Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
-
8741
Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
8742
Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
8743
Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
8744
Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
8745
-
8746
-
8747
-
8748
Schematic representation showing different phases and outcomes of stochastic bubbles for (4) with <i>b</i> = 0.42, <i>g</i> = −0.04, <i>σ</i><sub><i>x</i></sub> = 0.6, <i>σ</i><sub...
Published 2018“…<b>(A)</b> and <b>(B)</b> Foreshocks {1/2} and {3/4} preceding the main crash {5/6} are clearly visible. The time intervals between the consecutive local peaks and corrections decrease as a result of at least two factors: first, until around <i>z</i> = 0.2, the price <i>x</i> accelerates making it prone to take a time consuming detour for smaller <i>x</i> {2} that becomes less impactful compared to when <i>x</i> is larger {4}. …”
-
8749
-
8750
-
8751
-
8752
-
8753
CD4<sup>+</sup>CD25<sup>hi</sup>FOXP3<sup>+</sup> Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel
Published 2015“…Cytokines responses (IFN-γ, IL-5, IL-10, IL-13, IL-17 and TNF) were integrated using Principal Component Analysis (PCA). …”
-
8754
-
8755
-
8756
Experiment 2D and 5D: Progressive Sample Scaling Algorithm To Solve Many-Affine BBOB Functions.
Published 2024“…Optionally, there is a factor value that can increase or decrease the number of points during execution in the Scaling stage.…”
-
8757
-
8758
-
8759
-
8760